FOCUS REVIEWS ON HEART FAILURE : Direct Reprogramming of Fibroblasts into Cardiomyocytes for Cardiac Regenerative Medicine

DOI Web Site Web Site PubMed 被引用文献2件 参考文献79件
  • Fu Ji-Dong
    Heart and Vascular Research Center, MetroHealth Campus of Case Western Reserve University Gladstone Institute of Cardiovascular Disease Roddenberry Center for Stem Cell Biology and Medicine at Gladstone
  • Srivastava Deepak
    Gladstone Institute of Cardiovascular Disease Roddenberry Center for Stem Cell Biology and Medicine at Gladstone Department of Pediatrics, University of California Department of Biochemistry and Biophysics, University of California

書誌事項

タイトル別名
  • Direct Reprogramming of Fibroblasts into Cardiomyocytes for Cardiac Regenerative Medicine

この論文をさがす

抄録

Cardiac fibroblasts play critical roles in maintaining normal cardiac function and in cardiac remodeling during pathological conditions such as myocardial infarction (MI). Adult cardiomyocytes (CMs) have little to no regenerative capacity; damaged CMs in the heart after MI are replaced by cardiac fibroblasts that become activated and transform into myofibroblasts, which preserves the structural integrity. Unfortunately, this process typically causes fibrosis and reduces cardiac function. Directly reprogramming adult cardiac fibroblasts into induced CM-like cells (iCMs) holds great promise for restoring heart function. Direct cardiac reprogramming also provides a new research model to investigate which transcription factors and microRNAs control the molecular network that guides cardiac cell fate. We review the approaches and characterization of in vitro and in vivo reprogrammed iCMs from different laboratories, and outline the future directions needed to translate this new approach into a practical therapy for damaged hearts. (Circ J 2015; 79: 245–254)

収録刊行物

  • Circulation Journal

    Circulation Journal 79 (2), 245-254, 2015

    一般社団法人 日本循環器学会

被引用文献 (2)*注記

もっと見る

参考文献 (79)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ